Recently updated online resources from prominent government entities, including the Food and Drug Administration (FDA) and the Substance Abuse and Mental Health Services Administration (SAMHSA), have introduced a significant disclaimer that dismisses “gender ideology.” This development, as highlighted by 404 Media, enables these agencies to adhere to a recent judicial directive mandating the restoration of previously deleted webpages. At the same time, it reflects a continued endorsement of the anti-trans executive order initiated by the Trump administration, which originally prompted the removal of these crucial pages.

The newly implemented disclaimer draws directly from the language utilized in President Trump’s executive order. It can be found on the FDA’s guidance document regarding the “Study of Sex Differences in the Clinical Evaluation of Medical Products” and on a page linking to findings from SAMHSA’s report focused on the “Behavioral Health of Adolescents across Sexual Identities.” However, this disclaimer appears inconsistently across various platforms; for instance, it is absent from a Centers for Disease Control and Prevention page discussing “Sexually Transmitted Infections Treatment Guidelines.

Below is a reproduction of the disclaimer’s wording:

In January, government agencies were instructed by the Office of Personnel Management (OPM) to “cease all agency programs that utilize taxpayer funds to promote or reflect gender ideology.” This directive led to the removal of various webpages, as reported by The Washington Post. Subsequently, Doctors of America, represented by Public Citizen, filed a lawsuit against OPM and other agencies regarding the webpage deletions based on safety concerns, which culminated in this month’s order to revert the websites to their former versions.